Action - BVF

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been promoted to Vice President, Finance and Controller...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11 /PRNewswire-FirstCall/ -- Biovail Corporation (TSX, NYSE:...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Conn...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The November 21, 2003 edition of the Wall Street Journal...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial Reporting COLCHESTER, Conn., Nov. 21 /PRNewswire/...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

BVF - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 0,00

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
BLUBlue Star Capital Plc	8,25p (230,00%)	2,73M
RCGHRc365 Holding Plc	3,25p (54,76%)	8,11M
BTCVinanz Limited	22,50p (34,33%)	872,26k
BANKFiinu Plc	0,65p (30,00%)	2,26M
TM1Technology Minerals Plc	0,145p (20,83%)	26,39M
NFXNuformix Plc	0,045p (-25,00%)	157,31M
EYEEagle Eye Solutions Group Plc	362,00p (-23,14%)	173,99k
GFINGfinity Plc	0,0625p (-16,67%)	56,22M
JWNGJaywing Plc	0,525p (-16,00%)	728,76k
SYMESupply@me Capital Plc	0,003p (-14,29%)	133,24M
TRPTower Resources Plc	0,0355p (-10,13%)	1,96B
ORCPOracle Power Plc	0,018p (-5,26%)	300,79M
LLOYLloyds Banking Group Plc	53,28p (0,76%)	193,8M
DGIDg Innovate Plc	0,0185p (-7,50%)	171,19M
NFXNuformix Plc	0,045p (-25,00%)	157,31M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Beta Vietnam Fd (BVF)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

BVF Dernières nouvelles

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Beta Vietnam Fd (BVF) Cours

Beta Vietnam Fd (BVF)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

BVF Dernières nouvelles

BVF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE